European Society for Paediatric Gastroenterology, Hepatology and Nutrition
Acronym: ESPGHAN
General Information
Identification Code: 360779750556-40
Website: [object Object]
Entity Form: Association
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 6/21/2023
Last Update: 3/1/2024
EP Accredited Number: 0
Mission & Interests
Goals: The European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) is a multi-professional organisation whose aim is to promote the health of children with special attention to the gastrointestinal tract, liver and nutritional status, through knowledge creation, the dissemination of science based information, the promotion of best practice in the delivery of care and the provision of high quality education for paediatric gastroenterology, hepatology and nutrition professionals in Europe and beyond. Our goals in liaising with the EU parliament come under three categories:
Raising awareness of the issue of Button Battery Ingestion in children and work with policymakers and industry partners to prevent BBI and save young lives.
Raising awareness of and address the shortage of paediatric medical devices in the EU.
Improving availability of paediatric drugs for Inflammatory Bowel Disease (IBD).
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Communication
- Education and training
- Research and innovation
- Youth
Levels of Interest:
- european
Activities
Main EU Legislative Proposals: EN 62115. Toy safety directive. ESPGHAN has launched a manifesto calling on industry and policy makers to develop regulation that mandates child-resistant button battery packaging alongside durable and secure battery compartments for products powered by button batteries and ensure effective enforcement of applicable rules. Affiliation with EPBA.
EU 2017/745 - Regulation of the European Union on the clinical investigation and sale of medical devices for human use. Transitional period until end date of May 26 2017.
EU 2023/0005 COD - Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices extension of transition period (as above) until December 31 2027 for class III and class IIb high-risk devices, and until December 31 2028 for medium- and low-risk devices.
Paediatric drugs - authorisation of paediatric IBD drugs
Communication Activities: BBI social media campaign - press releases, awareness day, guidelines (https://www.espghan.org/knowledge-center/education/ESPGHAN-BBI-Awareness-Day-2023), publications (https://www.espghan.org/knowledge-center/publications/Gastroenterology/2021-Diagnosis--Management--and-Prevention-of-Button-Battery-Ingestion-in-Childhood)
Medical devices - publications, letter, survey (https://www.espghan.org/our-organisation/Announcements/ESPGHAN-Medical-Devices-Survey).
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: ESPGHAN OfficeRue Pellegrino Rossi 16
Post Code: 1021
City: Geneva
Country: SWITZERLAND
Phone: [object Object]
EU Office
Address: ESPGHAN OfficeRue Pellegrino Rossi 16
Post Code: 1021
City: Geneva
Country: SWITZERLAND
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 0.25
Info Members: Liaison Officer mandated at 0.3 FTE
Structure
Structure Type: Structure
Is Member Of: https://www.espghan.org/our-organisation/related-organisations
Organisation Members: FISPGHAN - https://www.fispghan.org/
UEG - https://ueg.eu/
BioMed Alliance - https://www.biomedeurope.org/